Navigation Links
A New Study Analyses Benefits Of Statin Drug

A new Canadian-led review on statin drug concluded that the drug has the potential to reduce the risk of heart attack and stroke in people with no history of cardiovascular// diseases. But the reduce in the risk of death cannot be assured by this cholesterol-lowering drug.

Statins, the best selling and widely used among the family of drugs, help the patients in lowering levels of artery-clogging 'bad' cholesterol, called LDL or low-density lipoprotein.

Dr. Paaladinesh Thevendiranathan of University of Toronto did the analysis along with his colleagues and the results were published in the Monday’s issue of Archieves of Internal Medicine. They concluded that statins help lowering the risk of heart attacks and strokes in people who are at risk from heart disease or high cholesterol otherwise the benefits are limited when healthy adults are considered.

An analysis of seven previous trials that involved nearly 43,000 adults aged 55 to 75 found that the average adult had a nearly 6 percent chance of suffering a heart attack over a 4 1/3-year period, compared with a 4 percent risk among those who took statins. 'Therefore, 60 patients would need to be treated for an average of 4.3 years to prevent one major coronary event,' the research team wrote in the article. Moreover 268 people would need to take statin treatment for preventing one stroke and 61 would have to take the drugs for preventing one nonfatal heart attack – the research team added.

Even though universal lipid-lowering therapy appears attractive, further studies are needed to clarify the cost-effectiveness of therapy in this (healthy) group. Drug-free ways such as improving your diet and exercising may be considered as an alternative ways, which also helps in lowering blood cholesterol levels.
SR
'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... ... -centric training, today announced the launch of a new research study, The Business ... skills needed to execute that strategy, and the actual success of achieving individual ...
(Date:3/27/2017)... ... , ... According to the American Cancer Society , the average 15-year ... Once the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year ... this latter group, tune in to Lifestyle Magazine on April 9, 2017, ...
(Date:3/27/2017)... ... 2017 , ... Golden Triangle Emergency Center will be hosting ... to commemorate the two-year anniversary of the facility. The event will feature refreshments ... years while also familiarizing themselves with the facility. , In the two years ...
(Date:3/25/2017)... ... 2017 , ... Getting earned media coverage meaningful for Garden Media Group's clients ... the year, Garden Media aims to provide material helpful to clients’ goals and bottom ... client’s key messages to gain coveted media placements, Garden Media wows clients year-round. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious disease ... hospitals in the United States, it’s a threat that is constantly changing and ... infection prevention and offers strategies for the healthcare community to help decrease the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: